Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease

Brain

Volumn 122, Issue 8, 1999, Pages 1519-1531

  Meguro, K ^c   Blaizot, X ^d   Kondoh, Y ^a   Le Mestric, C ^d   Baron, J C ^b   Chavoix, C ^d  

^a RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^b GIP CYCERON   (France)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NONE

Author keywords

Baboon; CMR(glc); Rhinal cortex; 18F fluoro 2 deoxy D glucose

Indexed keywords

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; BRAIN CORTEX; BRAIN INJURY; BRAIN METABOLISM; BRAIN REGION; BRAIN SURGERY; CELL LOSS; CHOLINERGIC SYSTEM; CINGULATE GYRUS; CONTROLLED STUDY; DISEASE COURSE; ENTORHINAL CORTEX; FOREBRAIN; GLUCOSE METABOLISM; HIPPOCAMPUS; MALE; NEOCORTEX; NERVE CELL DEGENERATION; NERVE CELL LESION; NEUROFIBRILLARY TANGLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIMATE; PRIORITY JOURNAL; TEMPORAL LOBE;

EID: 0032863636     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.8.1519     Document Type: Article

References (64)

1. Amaral DG, Insausti R, Cowan WM. The entorhinal cortex of the monkey: I. Cytoarchitectonic organization. J Comp Neurol 1987; 264: 326-55.
2. Beck T, Weber M, Horvath E, Wree A. Functional cerebral activity during regeneration from entorhinal lesions in the rat. J Cereb Blood Flow Metab 1996; 16: 342-52.
3. Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 1983; 40: 711-14.
4. Blaizot X, Meguro K, Le Mestric C, Hansen F, Benali K, Baron JC, et al. Effects of combined neurotoxic lesions of the entorhinal and perirhinal cortices on brain glucose utilization (CMRglc) and declarative memory in baboons. J Cereb Blood Flow Metab 1997; 17 Suppl 1: S639.
5. Blaizot X, Meguro K, Le Mestric C, Constans J-M, Luet D, Baron JC, et al. Combined use of T1-weighted MRI and MRA for stereotaxic lesioning of the nonhuman primate brain: application to the rhinal cortex. Exp Brain Res 1999; 126: 31-4.
6. Bonin G von, Bailey P. The neocortex of Macaca mulatta. Urbana (IL): University of Illinois Press; 1947.
7. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. [Review]. Acta Neuropathol (Berl) 1991; 82: 239-59.
8. Chavoix C, Baron JC. PET investigations in the non-human primate in relation to neuropsychology: methodological issues. In: Boller F, Grafman J, editors. Handbook of neuropsychology, Vol. 10. Amsterdam: Elsevier; 1995. p. 483-92.
9. Cutler NR, Haxby JV, Duara R, Grady CL, Kay AD, Kessler RM, et al. Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease. Ann Neurol 1985; 18: 298-309.
10. Delacourte A, David JP, Sergeant N, Buée L, Waltez A, Vermersch P, et al. The biochemical pathways of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999; 52: 1158-65.
11. Desgranges B, Baron JC, de la Sayette V, Petit-Taboué MC, Benali K, Landeau B, et al. The neural substrates of memory systems impairment in Alzheimer's disease: a PET study of resting brain glucose utilization. Brain 1998; 121: 611-31.
12. Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, et al. Positron emission tomography in Alzheimer's disease. Neurology 1986; 36: 879-87.
13. Fitch W, McGeorge AP, MacKenzie ET. Anaesthesia for studies of the cerebral circulation: a comparison of phencyclidine and althesin in the baboon. Br J Anaesth 1978; 50: 985-91.
14. Foster NL, PET imaging. In: Terry RD, Katzman R, Bick KL, editors. Alzheimer disease. New York: Raven Press; 1994. p. 87-103.
15. Frackowiak RS, Pozzilli C, Legg NJ, du Boulay GH, Marshall J, Lenzi GL, et al. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 1981; 104: 753-78.
16. Fukuyama H, Harada K, Yamauchi H, Miyoshi T, Yamaguchi S, Kimura J, et al. Coronal reconstruction images of glucose metabolism in Alzheimer's disease. J Neurol Sci 1991; 106: 128-34.
17. Gaffan D, Murray EA. Monkeys (Macaca fascicularis) with rhinal cortex ablations succeed in object discrimination learning despite 24-hr intertrial intervals and fail at matching to sample despite double sample presentations. Behav Neurosci 1992; 106: 30-8.
18. Geaney DP, Soper N, Shepstone BJ, Cowen PJ. Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease [see comments]. Lancet 1990; 335: 1484-7. Comment in: Lancet 1990; 336: 450.
19. Geaney DP, Soper N, Shepstone BJ, Cowen PJ. Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease [see comments]. Lancet 1990; 335: 1484-7. Comment in: Lancet 1990; 336: 450.
20. Goldman-Rakic PS, Selemon LD, Schwartz ML. Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience 1984; 12: 719-43.
21. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996; 16: 4491-500.
22. Grady CL, Haxby JV, Schapiro MB, Gonzalez-Aviles A, Kumar A, Ball MJ, et al. Subgroups in dementia of the Alzheimer type identified using positron emission tomography. J Neuropsychiatry Clin Neurosci 1990; 2: 373-84.
23. Haxby JV. Cognitive deficits and local metabolic changes in dementia of the Alzheimer type. In: Rapoport SR, Petit H, Leys D, Christen Y, editors. Imaging, cerebral tomography and Alzheimer's disease. Berlin: Springer-Verlag; 1990. p. 110-9.
24. Insausti R, Amaral DG, Cowan WM. The entorhinal cortex of the monkey: II. Cortical afferents. J Comp Neurol 1987; 264: 356-95.
25. Ishii K, Kitagaki H, Kono M, Mori E. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET. J Nucl Med 1996; 37: 1159-65.
26. Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E. Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease. J Nucl Med 1998; 39: 293-8.
27. Jagust WJ, Eberling JL, Richardson BC, Reed BR, Baker MG, Nordahl TE, et al. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease. Brain Res 1993; 629: 189-98.
28. Jobst KA, Smith AD, Barker CS, Wear A, King EM, Smith A, et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992; 55: 190-4.
29. Jorgensen MB, Wright DC. The effect of unilateral and bilateral removal of the entorhinal cortex on the glucose utilization in various hippocampal regions in the rat. Neurosci Lett 1988; 87: 227-32.
30. Julin P, Lindqvist J, Svensson L, Slomka P, Wahlund LO. MRI-guided SPECT measurements of medial temporal lobe blood flow in Alzheimer's disease. J Nucl Med 1997; 38: 914-9.
31. Juottonen K, Laakso MP, lnsausti R, Lehtovirta M, Pitkanen A, Partanen K, et al. Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease. Neurobiol Aging 1998; 19: 15-22.
32. Kennedy AM, Rossor MN, Frackowiak RS. Positron emission tomography in familial Alzheimer disease. Alzheimer Dis Assoc Disord 1995; 9: 17-20.
33. Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, et al. High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 1991; 4: 35-46.
34. Kurumaji A, McCulloch J. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats following unilateral lesion of caudal entorhinal cortex. Brain Res 1990; 531: 72-82.
35. Le Mestric C, Chavoix C, Miyazawa H, Tillet I, Allain P, Luet D, et al. Progress with magnetic resonance imaging (MRI) and positron emission tomography (PET). In: Uemura K, Lassen NA, Joues T, Kanno I. editors. Quantification of brain function. Tracer kinetics and image analysis in Brain PET. Amsterdam: Elsevier; 1993. p. 475-85.
36. Le Mestric C, Chavoix C, Chapon F, Mézenge F, Epelbaum J, Baron JC. Effects of damage to the basal forebrain on brain glucose utilization: a reevaluation using positron emission tomography in baboons with extensive unilateral excitotoxic lesion. J Cereb Blood Flow Metab 1998; 18: 476-90.
37. Lynch G, Matthews DA, Mosco S, Parks T, Cotman CW. Induced acetylcholinesterase-rich layer in rat dentate gyrus following entorhinal lesions. Brain Res 1972; 42: 311-8.
38. Matthews DA, Cotman C, Lynch G. An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. II. Reappearance of morphologically normal synaptic contacts. Brain Res 1976; 115: 23-41.
39. Meguro K, Doi C, Ueda M, Yamaguchi T, Matsui H, Kinomura S, et al. Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia. Neuroradiology 1991; 33: 305-9.
40. Meguro K, Chavoix C, Blaizot X, Le Mestric C, Hansen F, MacKenzie ET, et al. Effects of a bilateral neurotoxic lesion of the rhinal cortex on cerebral glucose utilization (CMRglc) in baboons: a PET study [abstract]. Soc Neurosci Abstr 1995; 21: 1723.
41. Meguro K, Chavoix C, Petit-Taboue MC, Verard L, Desgranges B, Eustache F, et al. Decreased temporo-parietal glucose utilization correlated with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. J Cereb Blood Flow Metab 1997; 17 Suppl 1: S581.
42. Meunier M, Bachevalier J, Mishkin M, Murray EA. Effects on visual recognition of combined and separate ablations of the entorhinal and perirhinal cortex in rhesus monkeys. J Neurosci 1993; 13: 5418-32.
43. Mielke R, Schröder R, Fink GR, Kessler J, Herholz K, Heiss WD. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol (Berl) 1996; 91: 174-9
44. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42: 85-94.
45. Miyazawa H, Osmont A, Petit-Taboue MC, Tillet I, Travere JM, Young AR, et al. Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography. J Neurosci Methods 1993; 50: 263-72.
46. Ohnishi T, Hoshi H, Nagamachi S, Jinnouchi S, Flores LG 2nd, Futami S, et al. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med 1995; 36: 1163-69.
47. Pearlson GD, Harris GJ, Powers RE, Barta PE, Camargo EE, Chase GA, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992; 49: 402-8.
48. Perani D, Grassi F, Sorbi S, Nacmias B, Piacentini S, Piersanti P, et al. PET study in subjects from two Italian FAD families with APP717 val to leu mutation. Eur J Neurol 1997; 4: 214-20.
49. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371-88.
50. Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, et al. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. Am J Psychiatry 1996; 153: 1261-8.
51. Poduri A, Beason-Held LL, Moss MB, Rosene DL, Hyman BT. CA3 neuronal degeneration follows chronic entorhinal cortex lesions. Neurosci Lett 1995; 197: 1-4.
52. Price JL, Morris JC. Tangles and plaques in non-demented aging and 'preclinical' Alzheimer's disease. Ann Neurol 1999; 45: 358-68.
53. Russchen FT, Amaral DG, Price JL. The afferent input to the magnocellular division of the mediodorsal thalamic nucleus in the monkey, Macaca fascicularis. J Comp Neurol 1987; 256: 175-210.
54. Strassburger T, Alexander GE, Brady DR, Mangot D, Pietrini P, Mentis M, et al. Heterogeneity of regional cerebral glucose metabolic patterns in neuropathologically confirmed Alzeimer's disease [abstract]. Neurology 1996; 46 (2 Suppl): A134.
55. Suzuki WA. Neuroanatomy of the monkey entorhinal, perirhinal and parahippocampal cortices: organisation of cortical inputs and interconnections with amygdala and striatum. Semin Neurosci 1996; 8: 3-12.
56. Suzuki WA, Amaral DG. Cortical inputs to the CA1 field of the monkey hippocampus originate from the perirhinal and parahippocampal cortex but not from area TE. Neurosci Lett 1990; 115: 43-8.
57. Suzuki WA, Amaral DG. Topographic organization of the reciprocal connections between the monkey entorhinal cortex and the perirhinal and parahippocampal cortices. J Neurosci 1994a; 14: 1856-77.
58. Suzuki WA, Amaral DG. Perirhinal and parahippocampal cortices of the macaque monkey: cortical afferents. J Comp Neurol 1994b; 350: 497-533.
59. Van Hoesen GW, Pandya DN. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. III. Efferent connections. Brain Res 1975; 95: 39-59.
60. Van Hoesen GW, Hyman BT, Damasio AR. Entorhinal cortex pathology in Alzheimer's disease. [Review]. Hippocampus 1991; 1: 1-8.
61. Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL. Basal forebrain lesions in monkeys disrupt attention but not learning and memory [published erratum appears in J Neurosci 1995; 15 (3Pt2): following table of contents]. J Neurosci 1994; 14: 167-86.
62. Webster MJ, Ungerleider LG, Bachevalier J. Connections of inferior temporal areas and TEO with medial temporal-lobe structures in infant and adult monkeys. J Neurosci 1991; 11: 1095-116.
63. Witter MP, Amaral DG. Entorhinal cortex of the monkey: V. Projections to the dentate gyms, hippocampus, and subicular complex. J Comp Neurol 1991; 307: 437-59.
64. Yamaguchi S, Meguro K, Itoh M, Hayasaka C, Shimada M, Yamazaki H, et al. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. J Neurol Neurosurg Psychiatry 1997; 62: 596-600.